New Biotech Company Fights Tough Diseases
Two drug companies joined forces, creating a new company with $125 million to develop medicines for scarring diseases.
Two drug companies, Skye Bioscience and Redx Pharma, just combined. They formed a new company called Fibrx Therapeutics. This new company has a big goal: to create medicines for fibrotic diseases. These diseases cause too much scarring in the body. They can harm organs like the lungs or liver.
The new company starts with $125 million. This money will help Fibrx Therapeutics work on its important drugs. The drugs come from both Skye and Redx. They aim to stop or reverse the damaging scarring that fibrotic diseases cause.
This partnership means more hope for patients. It speeds up the work on new treatments. Fibrx Therapeutics now has the funds and research to push forward. They are moving closer to solutions for these serious health problems.
Source: FierceBiotech
More from Biotech
